Literature DB >> 34980564

Physiology and Clinical Utility of HeartMate Pump Parameters.

Mark N Belkin1, Viktoriya Kagan2, Colleen Labuhn2, Sean P Pinney1, Jonathan Grinstein3.   

Abstract

The HeartMate 3 left ventricular assist device (LVAD) is now the only centrifugal pump intended for durable support being actively manufactured and implanted for adults in the United States. The changes in preload and afterload that accompany common clinical scenarios experienced by patients with an LVAD will cause specific changes to the LVAD pump parameters, namely, the pump power, pulsatility index, and flow. Appropriate care of this unique, and growing, population requires a full understanding of these variables as well as the underlying physiologic principles governing their derivation. The aim of this review is to focus on the updated functionality of the HeartMate 3, specifically in comparison to the HeartMate II, as well as the application of pump parameter interpretation to common clinical scenarios.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HeartMate; Left ventricular assist device; pulsatility index; pump parameters

Mesh:

Year:  2021        PMID: 34980564      PMCID: PMC9106934          DOI: 10.1016/j.cardfail.2021.11.016

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   6.592


  36 in total

Review 1.  Arterial stiffness and vascular load in heart failure.

Authors:  Henry Ooi; William Chung; Andreia Biolo
Journal:  Congest Heart Fail       Date:  2008 Jan-Feb

Review 2.  Management of aortic insufficiency in the continuous flow left ventricular assist device population.

Authors:  Jonathan Holtz; Jeffrey Teuteberg
Journal:  Curr Heart Fail Rep       Date:  2014-03

3.  Left Ventricular Assist Device Performance Under Pressure: Troubleshooting Outflow Graft Dysfunction.

Authors:  Mark N Belkin; Joseph Venturini; Sandeep Nathan; Jonathan Grinstein
Journal:  Circ Heart Fail       Date:  2020-07-01       Impact factor: 8.790

4.  Left ventricular assist devices are underutilized.

Authors:  Leslie W Miller
Journal:  Circulation       Date:  2011-04-12       Impact factor: 29.690

5.  Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

Authors:  Veli K Topkara; A Reshad Garan; Barry Fine; Amandine F Godier-Furnémont; Alexander Breskin; Barbara Cagliostro; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Donna M Mancini; Yoshifumi Naka; Paolo C Colombo
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

6.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.

Authors:  Sang-Woo Pak; Nir Uriel; Hiroo Takayama; Sarah Cappleman; Robert Song; Paolo C Colombo; Sandy Charles; Donna Mancini; Linda Gillam; Yoshifumi Naka; Ulrich P Jorde
Journal:  J Heart Lung Transplant       Date:  2010-07-08       Impact factor: 10.247

7.  Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device.

Authors:  James O Mudd; Jonathan D Cuda; Marc Halushka; Karl A Soderlund; John V Conte; Stuart D Russell
Journal:  J Heart Lung Transplant       Date:  2008-10-26       Impact factor: 10.247

8.  The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications.

Authors:  Jeffrey J Teuteberg; Joseph C Cleveland; Jennifer Cowger; Robert S Higgins; Daniel J Goldstein; Mary Keebler; James K Kirklin; Susan L Myers; Christopher T Salerno; Josef Stehlik; Felix Fernandez; Vinay Badhwar; Francis D Pagani; Pavan Atluri
Journal:  Ann Thorac Surg       Date:  2020-03       Impact factor: 4.330

9.  The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.

Authors:  Jeffrey J Teuteberg; Mark S Slaughter; Joseph G Rogers; Edwin C McGee; Francis D Pagani; Robert Gordon; Eduardo Rame; Michael Acker; Robert L Kormos; Christopher Salerno; Thomas P Schleeter; Daniel J Goldstein; Julia Shin; Randall C Starling; Thomas Wozniak; Adnan S Malik; Scott Silvestry; Gregory A Ewald; Ulrich P Jorde; Yoshifumi Naka; Emma Birks; Kevin B Najarian; David R Hathaway; Keith D Aaronson
Journal:  JACC Heart Fail       Date:  2015-10       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.